Federico
Martinón Torres
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (176)
2024
-
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants
Journal of Infectious Diseases, Vol. 229, pp. S112-S119
-
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases
-
Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» [Arch Bronconeumol. 2024;60(3):161–170] (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))
Archivos de Bronconeumologia
-
External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care
The Journal of infectious diseases, Vol. 229, Núm. 1, pp. S18-S24
-
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
The Journal of experimental medicine, Vol. 221, Núm. 2
-
Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia
Genes and Diseases, Vol. 11, Núm. 3
-
Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
Emerging Microbes and Infections
-
New Vaccines for Chronic Respiratory Patients
Archivos de Bronconeumologia
-
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453
-
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 161-170
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
-
Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study
Journal of Infectious Diseases
-
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Nature Communications, Vol. 15, Núm. 1
-
Which low urgent triaged febrile children are suitable for a fast track? An observational European study
Emergency Medicine Journal, Vol. 41, Núm. 4, pp. 236-241
2023
-
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)
Vaccine, Vol. 41, Núm. 21, pp. 3387-3398
-
A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study
The Lancet. Digital health, Vol. 5, Núm. 11, pp. e774-e785